AIM ImmunoTech Inc. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-023750
- Form type
- 10-Q
- CIK
- 0000946644
- Primary document
- https://www.sec.gov/Archives/edgar/data/946644/000149315226023750/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AIM ImmunoTech Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $22,000 | - | - |
| Operating Income | $-2.2M | - | - |
| Net Income | $-3.0M | - | - |
| Eps Basic | -0.69 | - | - |
| Eps Diluted | -0.69 | - | - |
| Cash And Equivalents | $5.8M | - | - |
| Total Assets | $8.6M | - | - |
| Total Liabilities | $6.5M | - | - |
| Shareholders Equity | $2.1M | - | - |
| Operating Cash Flow | $-2.7M | - | - |